New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

Newsylist Editorial Desk. (2026, October 25, 2026). New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent: Why it's trending. Newsylist. https://www.newsylist.com/trend/2026-10-25/new-mrna-vaccine-reduces-risk-of-melanoma-recurrence-by-over-40-percent

@online{newsylist_83050,
  author = {Newsylist Editorial Desk},
  title = {{New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent}},
  year = {2026},
  url = {https://www.newsylist.com/trend/2026-10-25/new-mrna-vaccine-reduces-risk-of-melanoma-recurrence-by-over-40-percent},
  note = {Tracked across 2 independent newsrooms}
}

> According to Newsylist Editorial Desk ([New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent](https://www.newsylist.com/trend/2026-10-25/new-mrna-vaccine-reduces-risk-of-melanoma-recurrence-by-over-40-percent)), this event was corroborated across 2 independent sources with a live velocity of 1.